Kim Dong Han, Chon Sung-Bin, Choi Ji Hun, Kwak Young Ho
Department of Emergency Medicine, CHA Bundang Medical Center, CHA University School of Medicine, Seongnam 13496, Republic of Korea.
Department of Emergency Medicine, CHA Bundang Medical Center, CHA University School of Medicine, Seongnam 13496, Republic of Korea.
Am J Emerg Med. 2022 Jan;51:401-408. doi: 10.1016/j.ajem.2021.03.007. Epub 2021 Mar 9.
Chon et al. suggested a high prevalence of severe hyperkalemia (serum potassium ≥ 6.0 mEq/L with electrocardiographic [ECG] changes) among patients with symptomatic or extreme bradycardia. Despite the urgent need to detect and treat severe hyperkalemia, serum potassium result may be available too late and is often spuriously high. Meanwhile, the traditional, descriptive ECG findings of severe hyperkalemia have shown unsatisfactory diagnostic powers. To overcome these diagnostic problems, they outlined the following quantitative rules to facilitate its early detection: Maximum precordial T wave ≥ 8.5 mV (2), atrial fibrillation/junctional bradycardia (1), heart rate (HR) ≤ 42/min (1) with (original rule)/without (ECG-only rule) diltiazem medication (2), and diabetes mellitus (1). Here we report on our external validation of these rules and the resulting updates.
This retrospective, cross-sectional study included all adults with symptomatic (HR ≤ 50/min with syncope/pre-syncope/dizziness, altered mentality, chest pain, dyspnea, general weakness, oliguria, or shock) or extreme (HR ≤ 40/min) bradycardia who visited a university emergency department from 2014 to 2019. After validating the abovementioned rules externally, we selected risk factors of severe hyperkalemia among the ECG findings and easy-to-assess clinical variables by multiple logistic regression analysis. After modelling the updated 'ECG-only' and 'ECG-plus' indices, we internally validated the better of the two by bootstrapping with 1000 iterations.
Among 455 symptomatic/extreme bradycardia cases (70.3 ± 13.1 years; 213 females [46.8%]), 70 (15.4%) had severe hyperkalemia. The previous ECG-only rule showed a c-statistic of 0.765 (95% CI: 0.706-0.825), Hosmer-Lemeshow test of p < 0.001, and a calibration slope of 0.719 (95% CI: 0.401-1.04). On updating, the ECG-plus index summing junctional bradycardia/atrial fibrillation (1), maximum precordial T wave≥8.0 mV (2), general weakness as the chief complaint (2), oxygen demand (1), and dialysis (2) outperformed the ECG-only index (c-statistic, 0.832; 95% CI, 0.785-0.880 vs. 0.764; 95% CI, 0.700-0.828; p = 0.011). On bootstrapping, the c-statistic was 0.832 (95% CI: 0.786-0.878). For scores ≥ 3 (positive likelihood ratio ≥ 5.0), the sensitivity and specificity were 0.514 and 0.901, respectively. For scores ≤ 1, negative likelihood ratio was ≤0.2.
Previous rules showed less satisfactory calibration but fair discrimination to detect severe hyperkalemia in patients with symptomatic or extreme bradycardia. We propose the ECG-plus index as the optimum tool to facilitate its early detection.
Chon等人指出,有症状性或极度心动过缓的患者中,严重高钾血症(血清钾≥6.0 mEq/L且伴有心电图[ECG]改变)的患病率较高。尽管迫切需要检测和治疗严重高钾血症,但血清钾结果可能获得过晚且常常假性升高。同时,严重高钾血症的传统描述性ECG表现诊断能力并不理想。为克服这些诊断问题,他们概述了以下定量规则以促进早期检测:胸前导联T波最大值≥8.5 mV(2分)、心房颤动/交界性心动过缓(1分)、心率(HR)≤42次/分钟(1分),服用(原规则)/未服用(仅ECG规则)地尔硫䓬药物(2分),以及糖尿病(1分)。在此,我们报告对这些规则的外部验证及由此产生的更新。
这项回顾性横断面研究纳入了2014年至2019年期间就诊于某大学急诊科的所有有症状性(HR≤50次/分钟且伴有晕厥/先兆晕厥/头晕、意识改变、胸痛、呼吸困难、全身无力、少尿或休克)或极度(HR≤40次/分钟)心动过缓的成年人。在对上述规则进行外部验证后,我们通过多因素逻辑回归分析在ECG表现及易于评估的临床变量中筛选严重高钾血症的危险因素。在构建更新后的“仅ECG”和“ECG加临床因素”指数后,我们通过1000次重复抽样进行内部验证,比较两者中较好的一个。
在455例有症状性/极度心动过缓的病例中(70.3±13.1岁;213例女性[46.8%]),70例(15.4%)患有严重高钾血症。先前的仅ECG规则的c统计量为0.765(95%CI:0.706 - 0.825),Hosmer - Lemeshow检验p<0.001,校准斜率为0.719(95%CI:0.401 - 1.04)。更新后的“ECG加临床因素”指数,即汇总交界性心动过缓/心房颤动(1分)、胸前导联T波最大值≥8.0 mV(2分)、以全身无力为主诉(2分)、氧需求(1分)和透析(2分),优于仅ECG指数(c统计量,0.832;95%CI,0.785 - 0.880对比0.764;95%CI,0.700 - 0.828;p = 0.011)。重复抽样时,c统计量为0.832(95%CI:0.786 - 0.878)。对于评分≥3(阳性似然比≥5.0),敏感性和特异性分别为0.514和0.901。对于评分≤1,阴性似然比≤0.2。
先前的规则校准不太理想,但在检测有症状性或极度心动过缓患者的严重高钾血症方面有一定的鉴别能力。我们建议将“ECG加临床因素”指数作为促进其早期检测的最佳工具。